Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myositis Clinical Trials
Myositis clinical trials are recruiting across 38 cities. Here are the cities with the most active studies:
Myositis Trial Phases
12 research organizations are sponsoring myositis trials.
About Myositis
Myositis refers to inflammatory conditions causing muscle weakness and inflammation. Dermatomyositis also involves skin rashes, while polymyositis primarily affects muscles closest to the trunk. Treatment includes corticosteroids, immunosuppressants, and physical therapy.
Clinical trials are advancing new treatments for myositis. Currently, 14 studies are recruiting a combined 8,858 participants across the United States. Research is being conducted by 12 organizations including National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Environmental Health Sciences (NIEHS), Myositis International Health & Research Collaborative Alliance Foundation and 9 others.
2026 Myositis Research Landscape
As of July 2026, the myositis clinical trial landscape includes 14 actively recruiting studies across 38 cities in the United States. These studies are collectively seeking 8,858 participants, with an average enrollment target of 633 per study.
The research spans multiple phases of development: 5 studies are in PHASE2, 4 studies are in PHASE3, 1 study is in PHASE1, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some myositis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 12 different organizations, including National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Environmental Health Sciences (NIEHS), Myositis International Health & Research Collaborative Alliance Foundation, Pfizer, University of Pennsylvania, and 7 others. The large number of sponsors reflects significant research interest and investment in myositis treatment advancement.
Geographically, myositis trials are most concentrated in Bethesda, Maryland (5 trials); Miami, Florida (3 trials); Atlanta, Georgia (2 trials); Research Triangle Park, North Carolina (2 trials); Boston, Massachusetts (2 trials) and 7 other cities.
Featured Myositis Studies
Highlighted recruiting studies for myositis, selected by enrollment size and research scope.
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
Purpose: The purpose of this protocol is 1. To comprehensively evaluate patients with autoinflammatory diseases clinically, genetically and immunologically at the autoinflammatory disease clinic at the NIH. 2. To follow patients with autoinflammatory Diseases that are genetically defined including Neonatal-Onset Multisystem Inflammatory Disease (NOMID), the most severe clinical phenotype of Cryop...
Adult and Juvenile Myositis
This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems associated with them. Myositis is an inflammatory muscle disease that can damage muscles and other organs, resulting in significant disability. Children or adults with polymyositis or dermatomyositis or a related condition may be evaluated u...
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing ...
Frequently Asked Questions About Myositis Clinical Trials
Are there myositis clinical trials near me?
Yes, there are 14 myositis clinical trials currently recruiting across 38+ cities in the United States, including Bethesda, Maryland; Miami, Florida; Atlanta, Georgia. Browse the studies above to find one at a location convenient for you.
How do I join a myositis clinical trial?
To join a myositis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myositis clinical trials free?
Yes, participation in myositis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myositis treatments are being studied?
Current myositis clinical trials are testing a range of approaches across PHASE2 (5 studies), PHASE3 (4 studies), PHASE1 (1 study), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 12 research organizations.
Is it safe to participate in myositis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 18, 2026 · Data from ClinicalTrials.gov